Specificity of HLA class I antigen recognition by human NK clones: evidence for clonal heterogeneity, protection by self and non-self alleles, and influence of the target cell type

Prior studies using polyclonal populations of natural killer (NK) cells have revealed that expression of certain major histocompatibility complex (MHC) class I molecules on the membrane of normal and transformed hematopoietic target cells can prevent NK cell-mediated cytotoxicity. However, the extent of clonal heterogeneity within the NK cell population and the effect of self versus non-self MHC alleles has not been clearly established. In the present study, we have generated more than 200 independently derived human NK cell clones from four individuals of known human histocompatibility leukocyte antigens (HLA) type. NK clones were analyzed for cytolytic activity against MHC class I-deficient Epstein Barr virus (EBV) transformed B lymphoblastoid cell lines (B-LCL) stably transfected with several HLA-A, -B, or -C genes representing either self or non-self alleles. All NK clones killed the prototypic HLA-negative erythroleukemia K562 and most lysed the MHC class I-deficient C1R and 721.221 B-LCL. Analysis of the panel of HLA- A, -B, and -C transfectants supported the following general conclusions. (a) Whereas recent studies have suggested that HLA-C antigens may be preferentially recognized by NK cells, our findings indicate that 70% or more of all NK clones are able to recognize certain HLA-B alleles and many also recognize HLA-A alleles. Moreover, a single NK clone has the potential to recognize multiple alleles of HLA-A, HLA-B, and HLA-C antigens. Thus, HLA-C is not unique in conferring protection against NK lysis. (b) No simple patterns of HLA specificity emerged. Examination of a large number of NK clones from a single donor revealed overlapping, yet distinct, patterns of reactivity when a sufficiently broad panel of HLA transfectants was examined. (c) Both autologous and allogeneic HLA antigens were recognized by NK clones. There was neither evidence for deletion of NK clones reactive with self alleles nor any indication for an increased frequency of NK clones recognizing self alleles. (d) With only a few exceptions, protection conferred by transfection of HLA alleles into B-LCL was usually not absolute. Rather a continuum from essentially no protection for certain alleles (HLA-A*0201) to very striking protection for other alleles (HLA-B*5801), with a wide range of intermediate effects, was observed. (e) Whereas most NK clones retained a relatively stable HLA specificity, some NK clones demonstrated variable and heterogeneous activity over time. (f) NK cell recognition and specificity cannot be explained entirely by the presence or absence of HLA class I antigens on the target cell.(ABSTRACT TRUNCATED AT 400 WORDS)

[1]  G. Szot,et al.  Hematopoietic cells and radioresistant host elements influence natural killer cell differentiation , 1993, The Journal of experimental medicine.

[2]  E. Brooks,et al.  Generation of allospecific natural killer cells by stimulation across a polymorphism of HLA-C. , 1993, Science.

[3]  D. Kaufman,et al.  MHC class I expression on tumor targets inhibits natural killer cell-mediated cytotoxicity without interfering with target recognition. , 1993, Journal of immunology.

[4]  A. Amoroso,et al.  Involvement of HLA class I alleles in natural killer (NK) cell-specific functions: expression of HLA-Cw3 confers selective protection from lysis by alloreactive NK clones displaying a defined specificity (specificity 2) , 1992, The Journal of experimental medicine.

[5]  D. Kaufman,et al.  Role for major histocompatibility complex class I in regulating natural killer cell-mediated killing of virus-infected cells. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[6]  J. Strominger,et al.  Alloantigen recognition by two human natural killer cell clones is associated with HLA-C or a closely linked gene. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[7]  W. Yokoyama,et al.  MHC class I alloantigen specificity of Ly-49+ IL-2-activated natural killer cells , 1992, Nature.

[8]  P. Parham,et al.  The HLA-A,B "negative" mutant cell line C1R expresses a novel HLA-B35 allele, which also has a point mutation in the translation initiation codon. , 1992, Journal of immunology.

[9]  J. Guardiola,et al.  Evidence of a natural killer (NK) cell repertoire for (allo) antigen recognition: definition of five distinct NK-determined allospecificities in humans , 1992, The Journal of experimental medicine.

[10]  H. Ljunggren,et al.  Restoration of a tumorigenic phenotype by beta 2-microglobulin transfection to EL-4 mutant cells , 1992, The Journal of experimental medicine.

[11]  L. Lanier,et al.  CD28 interaction with B7 costimulates primary allogeneic proliferative responses and cytotoxicity mediated by small, resting T lymphocytes , 1992, The Journal of experimental medicine.

[12]  P. Cresswell,et al.  Class I-induced resistance to natural killing: identification of nonpermissive residues in HLA-A2. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[13]  R. Jaenisch,et al.  MHC class I deficiency: susceptibility to natural killer (NK) cells and impaired NK activity. , 1991, Science.

[14]  L. Lanier,et al.  Multicolor immunofluorescence and flow cytometry , 1991 .

[15]  P. Parham,et al.  Peptide binding to empty HLA-B27 molecules of viable human cells , 1991, Nature.

[16]  R. Jaenisch,et al.  Rejection of class I MHC-deficient haemopoietic cells by irradiated MHC-matched mice , 1991, Nature.

[17]  M. Colonna,et al.  Susceptibility or resistance to lysis by alloreactive natural killer cells is governed by a gene in the human major histocompatibility complex between BF and HLA-B , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[18]  E. Ciccone,et al.  Identification of four subsets of human CD3-CD16+ natural killer (NK) cells by the expression of clonally distributed functional surface molecules: correlation between subset assignment of NK clones and ability to mediate specific alloantigen recognition , 1990, The Journal of experimental medicine.

[19]  E. Shevach,et al.  Chromosomal location of the Ly-49 (A1, YE1/48) multigene family. Genetic association with the NK 1.1 antigen. , 1990, Journal of immunology.

[20]  M. Davis,et al.  Expression of T cell antigen receptor heterodimers in a lipid-linked form. , 1990, Science.

[21]  H. Ljunggren,et al.  Transfection of beta 2-microglobulin restores IFN-mediated protection from natural killer cell lysis in YAC-1 lymphoma variants. , 1990, Journal of immunology.

[22]  J. Guardiola,et al.  Specific recognition of human CD3-CD16+ natural killer cells requires the expression of an autosomic recessive gene on target cells , 1990, The Journal of experimental medicine.

[23]  P. Parham,et al.  A binding site for the T-cell co-receptor CD8 on the α3 domain of HLA-A2 , 1990, Nature.

[24]  J. Roder,et al.  Class I (H‐2Kb) gene transfection reduces susceptibility of YAC‐1 lymphoma targets to natural killer cells , 1990, European journal of immunology.

[25]  H. Ljunggren,et al.  In search of the 'missing self': MHC molecules and NK cell recognition. , 1990, Immunology today.

[26]  G. Trinchieri,et al.  Biology of Natural Killer Cells , 1989, Advances in Immunology.

[27]  R. Demars,et al.  Production of human cells expressing individual transferred HLA-A,-B,-C genes using an HLA-A,-B,-C null human cell line. , 1989, Journal of immunology.

[28]  J. A. Payne,et al.  Reversal of natural killing susceptibility in target cells expressing transfected class I HLA genes. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[29]  J. Leiden,et al.  Susceptibility to natural killer cell-mediated cytolysis is independent of the level of target cell class I HLA expression. , 1989, Journal of immunology.

[30]  R. Demars,et al.  Demonstration by class I gene transfer that reduced susceptibility of human cells to natural killer cell‐mediated lysis is inversely correlated with HLA class I antigen expression , 1989, European journal of immunology.

[31]  G. Powis,et al.  Signal transduction during human natural killer cell activation: inositol phosphate generation and regulation by cyclic AMP. , 1988, Journal of immunology.

[32]  Eric O Long,et al.  Specific lysis of allogeneic cells after activation of CD3- lymphocytes in mixed lymphocyte culture , 1988, The Journal of experimental medicine.

[33]  P. Parham,et al.  Cell-cell adhesion mediated by CD8 and MHC class I molecules , 1988, Nature.

[34]  B. Fredholm,et al.  Phosphoinositide breakdown and evidence for protein kinase C involvement during human NK killing. , 1988, Cellular immunology.

[35]  T. Steele,et al.  Phosphatidylinositol metabolism accompanies early activation events in tumor target cell-stimulated human natural killer cells. , 1988, Cellular immunology.

[36]  P. Parham,et al.  In vitro mutagenesis at a single residue introduces B and T cell epitopes into a class I HLA molecule , 1987, The Journal of experimental medicine.

[37]  W. Seaman,et al.  Inositol trisphosphate is generated by a rat natural killer cell tumor in response to target cells or to crosslinked monoclonal antibody OX-34: possible signaling role for the OX-34 determinant during activation by target cells. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[38]  P. Cresswell,et al.  NK susceptibility varies inversely with target cell class I HLA antigen expression. , 1987, Journal of immunology.

[39]  H. Orr,et al.  Organization of the human class I major histocompatibility complex genes , 1987, Immunologic research.

[40]  L. Lanier,et al.  Natural killer cells: definition of a cell type rather than a function. , 1986, Journal of immunology.

[41]  H. Ljunggren,et al.  Selective rejection of H–2-deficient lymphoma variants suggests alternative immune defence strategy , 1986, Nature.

[42]  G. Klein,et al.  YAC-1 MHC class I variants reveal an association between decreased NK sensitivity and increased H-2 expression after interferon treatment or in vivo passage. , 1985, Journal of immunology.

[43]  T. Kipps,et al.  Functional properties of a unique subset of cytotoxic CD3+ T lymphocytes that express Fc receptors for IgG (CD16/Leu-11 antigen) , 1985, The Journal of experimental medicine.

[44]  H. Ljunggren,et al.  Host resistance directed selectively against H-2-deficient lymphoma variants. Analysis of the mechanism , 1985, The Journal of experimental medicine.

[45]  P. Parham,et al.  Exon shuffling in vivo can generate novel HLA class I molecules. , 1985, The EMBO journal.

[46]  P. Parham,et al.  The complete primary structure of HLA-Bw58. , 1985, The Journal of biological chemistry.

[47]  G. Evans,et al.  Construction of novel class I histocompatibility antigens by interspecies exon shuffling. , 1985, Journal of immunology.

[48]  W. V. van Blitterswijk,et al.  Serum-free medium for generation and propagation of functional human cytotoxic and helper T cell clones. , 1984, Journal of immunological methods.

[49]  T. Strachan,et al.  Complete nucleotide sequence of a gene encoding a functional human class I histocompatibility antigen (HLA‐CW3). , 1984, The EMBO journal.

[50]  G F Babcock,et al.  Subpopulations of human natural killer cells defined by expression of the Leu-7 (HNK-1) and Leu-11 (NK-15) antigens. , 1983, Journal of immunology.

[51]  G. Trinchieri,et al.  A human NK and K cell subset shares with cytotoxic T cells expression of the antigen recognized by antibody OKT8. , 1983, Journal of immunology.

[52]  P. Edwards,et al.  A human‐human hybridoma system based on a fast‐growing mutant of the ARH‐77 plasma cell leukemia‐derived line , 1982, European journal of immunology.

[53]  P. Parham,et al.  A monoclonal antibody that recognizes an antigenic determinant shared by HLA A2 and B17. , 1980, Human immunology.

[54]  F. Bach,et al.  Gamma ray-induced loss of expression of HLA and glyoxalase I alleles in lymphoblastoid cells. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[55]  W. Rutter,et al.  Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. , 1979, Biochemistry.

[56]  M. Torres,et al.  Nomenclature for factors of the HLA system. , 2011, Bulletin of the World Health Organization.

[57]  R. Kiessling,et al.  „Natural”︁ killer cells in the mouse. I. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Specificity and distribution according to genotype , 1975, European journal of immunology.

[58]  H. Ljunggren,et al.  Recognition of ,62-microglobulin-negative (f82mT) T-cell blasts by natural killer cells from normal but not from f2m mice: Nonresponsiveness controlled by fi2m bone marrow in chimeric mice , 2022 .